Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Clinical Colorectal Cancer|March 12, 2016
PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer ConsortiumDominick Bossé, Jamison Mercer, Soundouss Raissouni, et al.European Urology Oncology|September 29, 2019
Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell CarcinomaAly-Khan A Lalani, Wanling Xie, David A Braun, et al.Journal for Immunotherapy of Cancer|January 23, 2018
Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinomaAly-Khan A Lalani, Wanling Xie, Dylan J Martini, et al.JCO Global Oncology|November 22, 2023
Trends of Utilization of Systemic Therapies for Metastatic Renal Cell Carcinoma in the Canadian Health Care SystemLuisa M Cardenas, Sunita Ghosh, Antonio Finelli, et al.British Journal of Cancer|April 21, 2018
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinomaGuillermo de Velasco, Stephanie A Wankowicz, Russell Madison, et al.JCO Global Oncology|February 29, 2020
Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large CohortsDominick Bossé, Wanling Xie, Xun Lin, et al.Cancer Immunology Research|February 14, 2018
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse EventsDylan J Martini, Lana Hamieh, Rana R McKay, et al.Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.Science (New York, N.Y.)|January 6, 2018
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A Margolis, Wenhua Gao, et al.Cancer Immunology Research|May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaRana R McKay, Dominick Bossé, Wanling Xie, et al.Pageof 5